Memorial Hermann Advantage HMO February 2019 Formulary Addendum

Size: px
Start display at page:

Download "Memorial Hermann Advantage HMO February 2019 Formulary Addendum"

Transcription

1 Memorial Hermann Advantage HMO February 2019 Formulary Addendum Changes may have occurred since the printing of your current Memorial Hermann Advantage HMO Formulary. Medications that may have been added or removed from the Formulary are listed below. Please retain this with your copy of the Formulary. This is not a complete list of drugs covered by our plan. For a complete listing or other questions, please call Customer Service at (TTY users call 711), 24 hours a day, seven (7) days a week or visit healthplan.memorialhermann.org/medicare. The Formulary may change at any time. You will receive notice when necessary. You must generally use network pharmacies to use your prescription drug benefit. Benefits, formulary, pharmacy network, and/or copayments/coinsurance may change on January 1, 2019, and from time to time during the year. Memorial Hermann Advantage HMO is provided by Memorial Hermann Health Plan, Inc., a Medicare Advantage organization with a Medicare contract. Enrollment in this plan depends on contract renewal. BvD May be covered under Medicare Part B or D depending upon the circumstances; Non-Formulary; PA Prior Authorization; QL Quantity Limit, dispense limit for 30 days unless otherwise noted; ST Step Therapy; LA Limited Access (This prescription may be available only at certain pharmacies), EFFECTIVE 01/01/2019 Auryxia TABLET 1 GM 210 MG(Fe) PA1 N/A BromSite SOLUTION % OPHTHALMIC 4 Cimduo Tablet MG 5 Estropipate TABLET 1.5 MG 1 CMS Required Deletion N/A Page 1 of 6

2 Humira Pen-CD/UC/HS Starter Pen- Injector Kit 80 MG/0.8ML Subcutaneous Humira Pen-Ps/UV Starter Pen-Injector Kit 80 MG/0.8ML & 40MG/0.4ML, 5 + PA1 5 + PA1 Subcutaneous Incassia Tablet 0.35 MG 1 Ketoprofen CAPSULE 75 MG 2 CMS Required Deletion N/A Trelegy Ellipta Aerosol Powder Breath Activated MCG/INH Inhalation 3 + ST1 Vestura TABLET MG 2 CMS Required Deletion N/A Xeljanz Tablet 10 MG 5 + PA1 RELEASE PARTICLES UNIT Zenpep Capsule Delayed Release Particles UNIT RELEASE PARTICLES UNIT RELEASE PARTICLES UNIT Zenpep Capsule Delayed Release Particles UNIT RELEASE PARTICLES 5000 UNIT EFFECTIVE 02/01/2019 Abiraterone Acetate Tablet 250 MG QL Adapalene Solution 0.1 % External 4 + PA1 Afeditab CR Tablet Extended Release 24 Hour 60 MG 1 CMS Required Deletion N/A Ampyra Tablet Extended Release 12 Hour 10 MG 5 + QL LA dalfarmpridine 10mg, 5 + QL 60 + Page 2 of 6

3 AndroGel GEL MG/1.25GM (1.62%) TRANSDERMAL AndroGel GEL 40.5 MG/2.5GM (1.62%) TRANSDERMAL AndroGel Pump GEL MG/ACT (1.62%) TRANSDERMAL , testosterone mg/mg, 3 + testosterone mg/mg, 3 + testosterone 20.25mg/actua, 3 + Arikayce Suspension 590 MG/8.4ML Inhalation 2 + PA1 Azelaic Acid Gel 15 % External 4 Braftovi Capsule 50 MG LA Braftovi Capsule 75 MG LA BuPROPion HCl ER (XL) Tablet Extended Release 24 Hour 450 MG Cefotaxime Sodium Solution Reconstituted 2 GM Injection Clinimix/Dextrose (2.75/5) SOLUTION 2.75 % Intravenous Clinimix/Dextrose (4.25/20) SOLUTION 4.25 % Intravenous CloBAZam Suspension 2.5 MG/ML 4 + QL 30 + ST2 Formulary Enhancement N/A 2 CMS Required Deletion N/A 4 + BvD CMS Required Deletion N/A 4 + BvD CMS Required Deletion N/A 4 + CloBAZam Tablet 10 MG 4 + QL 60 + CloBAZam Tablet 20 MG 4 + QL 60 + Colesevelam HCl Packet 3.75 GM 3 Copiktra Capsule 15 MG 5 + QL LA Copiktra Capsule 25 MG 5 + QL LA Cyred EQ Tablet MG-MCG 1 DAPTOmycin Solution Reconstituted 350 MG Intravenous 4 + PA1 Delstrigo Tablet MG 5 Page 3 of 6

4 , Epidiolex Solution 100 MG/ML 4 + Ertapenem Sodium Solution Reconstituted 1 GM Injection 4 Finacea GEL 15 % EXTERNAL 4 azelaic acid 0.15mg/mg, 4 bupropion Forfivo XL Tablet Extended Release QL 30 hydrochloride Hour 450 MG + ST2 450mg, 4 + QL 30 + ST2 Hexalen CAPSULE 50 MG 5 + CMS Required Deletion N/A INVanz Solution Reconstituted 1 GM Injection 4 Itraconazole Solution 10 MG/ML 4 + PA1 Ketoprofen Capsule 25 MG 2 Kimidess Tablet /0.01 MG ertapenem 1000mg, 4 2 CMS Required Deletion N/A (21/5) Lenvima 12 MG Daily Dose Capsule Therapy Pack 4 (3) MG 5 + Lenvima 4 MG Daily Dose Capsule Therapy Pack 4 MG 5 + Lorbrena Tablet 100 MG 5 + Lorbrena Tablet 25 MG 5 + Mektovi Tablet 15 MG LA Molindone HCl Tablet 10 MG 2 Molindone HCl Tablet 25 MG 2 Molindone HCl Tablet 5 MG 2 Morphine Sulfate ER Capsule Extended Release 24 Hour 40 MG 2 Nafcillin Sodium Solution Reconstituted 2 GM Injection 2 Necon 7/7/7 Tablet 0.5/0.75/1-35 MG- MCG 1 CMS Required Deletion N/A Norvir CAPSULE 100 MG 4 CMS Required Deletion N/A Onfi SUSPENSION 2.5 MG/ML Onfi TABLET 10 MG QL 60 + clobazam 2.5mg/ml, 4 + clobazam 10mg, 4 + QL 60 + Page 4 of 6

5 Onfi TABLET 20 MG 5 + QL 60 +, clobazam 20mg, 4 + QL 60 + Orilissa Tablet 150 MG 5 + PA1 Orilissa Tablet 200 MG 5 + PA1 Orkambi Packet MG 5 + PA1 + LA Orkambi Packet MG 5 + PA1 + LA Periogard Solution 0.12 % Mouth/Throat 2 CMS Required Deletion N/A Pifeltro Tablet 100 MG 5 Sodium Chloride Solution 2.5 MEQ/ML Injection 2 CMS Required Deletion N/A Symtuza Tablet MG 5 Takhzyro Solution 300 MG/2ML Subcutaneous 5 + PA1 + LA Talzenna Capsule 0.25 MG LA Talzenna Capsule 1 MG LA Testosterone Gel MG/1.25GM 3 + (1.62%) Transdermal Testosterone Gel MG/ACT (1.62%) Transdermal 3 + Testosterone Gel 40.5 MG/2.5GM (1.62%) Transdermal 3 + Tibsovo Tablet 250 MG LA Tiglutik Suspension 50 MG/10ML 4 + PA1 Triamcinolone Acetonide Aerosol 55 MCG/ACT Nasal 2 CMS Required Deletion N/A Vancomycin HCl Solution Reconstituted 250 MG Intravenous 2 + BvD Versacloz Suspension 50 MG/ML 5 + ST2 CMS Required Deletion N/A Vizimpro Tablet 15 MG 5 + QL 30 + Vizimpro Tablet 30 MG 5 + QL 30 + Vizimpro Tablet 45 MG 5 + QL 30 + Page 5 of 6

6 , Welchol Packet 3.75 GM 3 colesevelam hydrochloride 3750mg, 2 Xarelto Tablet 2.5 MG 3 Xofluza Tablet Therapy Pack 20 (2) MG 4 + QL 2/365 Xofluza Tablet Therapy Pack 40 (2) MG 4 + QL 2/365 Xolair Solution Prefilled Syringe QL 6/28 + MG/ML Subcutaneous PA1 + LA Xolair Solution Prefilled Syringe QL 6/28 + MG/0.5ML Subcutaneous PA1 + LA Zortress Tablet 1 MG 5 + Zytiga TABLET 250 MG 5 + QL abiraterone acetate 250mg, 5 + QL Page 6 of 6

2019 Formulary Update

2019 Formulary Update MEDICARE ADVANTAGE BlueShield of Northeastern New York Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January. This document

More information

Health Partners Medicare Prime 2019 Formulary Changes

Health Partners Medicare Prime 2019 Formulary Changes Health Partners Medicare Prime 2019 Formulary Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes

More information

Notice of Mid-Year Changes to 2019 Paramount Enhanced Formulary

Notice of Mid-Year Changes to 2019 Paramount Enhanced Formulary Notice of Mid-Year s to 2019 Paramount Enhanced Formulary Paramount Elite (HMO) may immediately remove a brand name drug on our List if we are replacing it with a new generic drug that will appear on the

More information

2018 CareOregon Advantage Part D Formulary Changes

2018 CareOregon Advantage Part D Formulary Changes 2018 CareOregon Advantage Part D Formulary Changes Abbreviations: AGE = Age Restriction; PA = Prior Authorization Required; QL = Quantity Limit; ST = Step Therapy Required; LD = Limited Distribution; BvD

More information

2018 Step Therapy (ST) Criteria

2018 Step Therapy (ST) Criteria 2018 Step Therapy (ST) Criteria Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a

More information

2016 Step Therapy (ST) Criteria

2016 Step Therapy (ST) Criteria 2016 Step Therapy (ST) Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a drug that

More information

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) 207 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Plus Plan (HMO) H5087-002, H5087-07 This is a listing of the changes that have occurred in our formulary.

More information

Alprazolam 0.25mg, 0.5mg, 1mg tablets

Alprazolam 0.25mg, 0.5mg, 1mg tablets Presbyterian Senior Care (HMO) / Presbyterian MediCare PPO Quantity Limits Effective November 1, 2014 For the most recent list of drugs or other questions, please contact the Presbyterian Customer Service

More information

2015 Step Therapy (ST) Criteria

2015 Step Therapy (ST) Criteria 2015 Step Therapy (ST) Some drugs require step therapy pre-approval. This means that your doctor must have you first try a different drug to treat your medical condition before we will cover a drug that

More information

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) 2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Best Plan (HMO) H5087-005 This is a listing of the changes that have occurred in our formulary. Please

More information

2014 Step Therapy Criteria (List of Step Therapy Criteria)

2014 Step Therapy Criteria (List of Step Therapy Criteria) Criteria Last Updated: November 1, 2014 2014 Step Therapy Criteria (List of Step Therapy Criteria) PLEASE READ CAREFULLY: IEHP MEDICARE DUALCHOICE (HMO SNP) REQUIRES YOU TO FIRST TRY CERTAIN DRUGS TO TREAT

More information

2017 Formulary Addendum Notice of Change

2017 Formulary Addendum Notice of Change 017 Formulary Addendum Notice of Change (Medicare Advantage Plans) WellCare Health Plans WellCare Choice (HMO), WellCare Essential (HMO-POS), WellCare Value (HMO) This is a listing of the changes that

More information

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria

Acyclovir Ointment. Aetna Better Health Pennsylvania. Products Affected. acyclovir ointment 5 % external Details. Criteria Medications that require Step Therapy (ST) require trial and failure of preferred formulary agents prior to their authorization. If the prerequisite medications have been filled within the specified time

More information

2017 Formulary Addendum Notice of Change (Prescription Drug Plans)

2017 Formulary Addendum Notice of Change (Prescription Drug Plans) 2017 Formulary Addendum Notice of Change (Prescription Drug Plans) WellCare Prescription Insurance, Inc. WellCare Classic (PDP) WellCare Extra (PDP) This is a listing of the changes that have occurred

More information

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018

ANTIDEPRESSANTS. Details. Step Therapy 2018 Last Updated: 8/21/2018 ANTIDEPRESSANTS EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 120 MG ORAL FETZIMA

More information

2017 Formulary Addendum Notice of Change

2017 Formulary Addendum Notice of Change 2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) WellCare Health Plans WellCare Access (HMO SNP), WellCare Liberty (HMO SNP), WellCare Reserve (HMO), WellCare Rx (HMO), WellCare Select

More information

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans)

2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) 2017 Formulary Addendum Notice of Change (Medicare Advantage Plans) Easy Choice Health Plan Easy Choice Freedom Plan (HMO SNP) H5087-001 This is a listing of the changes that have occurred in our formulary.

More information

2017 Medicare Part D Formulary Change

2017 Medicare Part D Formulary Change 2017 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy

More information

PPHP 2017 Formulary 2017 Step Therapy Criteria

PPHP 2017 Formulary 2017 Step Therapy Criteria ARISTADA Aristada Prefilled Syringe 1064 MG/3.9ML Intramuscular Aristada Prefilled Syringe 441 MG/1.6ML Intramuscular Aristada Prefilled Syringe 662 MG/2.4ML Intramuscular Aristada Prefilled Syringe 882

More information

You ll find the most up-to-date comprehensive version of our formulary on our website, Click on Drug Finder.

You ll find the most up-to-date comprehensive version of our formulary on our website,   Click on Drug Finder. 3/1/2018 Medicare Part D Formulary Change In an effort to cover the most needed, cost-effective prescriptions, the AlohaCare Advantage Plus (HMO SNP) Formulary is updated monthly. The following are drugs

More information

ARISTADA. Products Affected Step 2: ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.

ARISTADA. Products Affected Step 2: ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1. ARISTADA ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.6ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 662 MG/2.4ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 882

More information

CARE N CARE HEALTH PLAN

CARE N CARE HEALTH PLAN ARISTADA Aristada Prefilled Syringe 441 MG/1.6ML Intramuscular Aristada Prefilled Syringe 662 MG/2.4ML Intramuscular Aristada Prefilled Syringe 882 MG/3.2ML Intramuscular Claim will pay automatically for

More information

2017 Formulary Addendum Notice of Change

2017 Formulary Addendum Notice of Change 2017 Formulary Addendum Notice of Change (Prescription Drug Plans) WellCare Prescription Insurance, Inc. WellCare Classic (PDP) WellCare Extra (PDP) This is a listing of the changes that have occurred

More information

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017

ANTIDEPRESSANTS. Details. Step Therapy 2017 Last Updated: 5/23/2017 ANTIDEPRESSANTS EMSAM PATCH 24 HOUR 12 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 6 MG/24HR TRANSDERMAL EMSAM PATCH 24 HOUR 9 MG/24HR TRANSDERMAL FETZIMA CAPSULE EXTENDED RELEASE 24 HOUR 120 MG FETZIMA CAPSULE

More information

CARE N CARE HEALTH PLAN

CARE N CARE HEALTH PLAN ARISTADA ARISTADA PREFILLED SYRINGE 1064 MG/3.9ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 441 MG/1.6ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 662 MG/2.4ML INTRAMUSCULAR ARISTADA PREFILLED SYRINGE 882

More information

WellCare s South Carolina Preferred Drug List Update

WellCare s South Carolina Preferred Drug List Update WellCare s South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on 09/21/2017.

More information

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum

WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum WellCare Signature (PDP) and WellCare Classic (PDP) Formulary Addendum This is a listing of the changes that have occurred in our formulary. Please carefully review these changes and call WellCare if you

More information

2019 Drug List Negative Changes

2019 Drug List Negative Changes 2019 Drug List Negative Changes Updated 03/26/2019 If you are taking a drug that is removed from the formulary (also known as the Drug List), we will tell you. We will also tell you if we add any restrictions

More information

2018 Formulary Update

2018 Formulary Update MEDICARE ADVANTAGE BlueShield of Northeastern New York 2018 Formulary Update BlueShield of Northeastern New York has updated its formulary (drug list) since its original publication in January 2018. This

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice MEDICAID PROVIDER BULLETIN March 2019 Quarterly pharmacy formulary change notice The formulary changes listed in the table below were reviewed and approved at the fourth quarter pharmacy and therapeutics

More information

2019 Drug List Negative Changes

2019 Drug List Negative Changes 2019 Drug List Negative Changes Updated 03/26/2019 If you are taking a drug that is removed from the formulary (also known as the Drug List), we will tell you. We will also tell you if we add any restrictions

More information

Y0133_StepTherapyCriteria _C 10/18/18 Y0133_StepTherapyCriteria _C es 10/18/18

Y0133_StepTherapyCriteria _C 10/18/18 Y0133_StepTherapyCriteria _C es 10/18/18 Step Therapy Grid Certain cost-effective drugs must be used before other more expensive drugs are covered. For example, certain brand-name medications will only be covered if a generic alternative has

More information

Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum

Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum Superior Select Health Plans: Tribute-1 Tier May 2018 Formulary Addendum Below is a list formulary changes for the benefit year 2018. This is not a complete list of drugs covered by the Part D plan. The

More information

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates

Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates Blue Cross and Blue Shield of Minnesota GenRx Formulary Updates July 2018 TRADE NAME (generic name) or generic name ADVAIR DISKUS (fluticasone-salmeterol aer powder ba 100-50 mcg/dose) Brand Addition ADVAIR

More information

2014 Quantity Limits (QL) Criteria

2014 Quantity Limits (QL) Criteria 2014 Quantity Limits (QL) Criteria Certain drugs covered through your EmblemHealth Medicare HMO/PPO Medicare Plan are covered for only a limited quantity. We do this to ensure compliance with the US Food

More information

2016 FORMULARY ADDENDUM NOTICE OF CHANGE

2016 FORMULARY ADDENDUM NOTICE OF CHANGE 2016 FORMULARY ADDENDUM NOTICE OF CHANGE (PRESCRIPTION DRUG PLANS) WELLCARE PRESCRIPTION INSURANCE, INC. WellCare Simple (PDP) WellCare Classic (PDP) WellCare Extra (PDP) This is a listing of the changes

More information

NOTIFICATION OF FORMULARY CHANGES

NOTIFICATION OF FORMULARY CHANGES NOTIFICATION OF CHANGES The following summary describes changes to the 2018 Presbyterian Senior Care (HMO)/(HMO-POS), Presbyterian MediCare PPO and formularies. The formulary may change at any time. You

More information

September 2018 Pharmacy & Therapeutics Committee Decisions

September 2018 Pharmacy & Therapeutics Committee Decisions UCare s Pharmacy and Therapeutics Committee (P&T) is a group of physicians and pharmacists that meet throughout the year to make changes to UCare (approved drug list). These changes are reviewed based

More information

Partners Notice of Change March 2017

Partners Notice of Change March 2017 New Added Products: Effective 3/1/2017 Drug Reason Tier Restrictions abacavir 600 mg-lamivudine 300 QL ADRENACLICK 0.15 MG/0.15 ML INJECTION,AUTO- INJECTOR ADRENACLICK 0.3 MG/0.3 ML INJECTION, AUTO- INJECTOR

More information

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir

Mercy Care Plan. Acyclovir Ointment. Products Affected. acyclovir ointment 5 % external Details. Criteria. Requires use of oral Acyclovir Acyclovir Ointment Mercy Care Plan acyclovir ointment 5 % external Requires use of oral Acyclovir 1 Adcirca ADCIRCA TABLET 20 MG ORAL Requires use of Sildenafil 2 Albenza ALBENZA TABLET 200 MG ORAL Requires

More information

Drugs That Require Step Therapy (ST)

Drugs That Require Step Therapy (ST) Saver Drugs That Require Step Therapy (ST) In some cases, Express Scripts Medicare (PDP) requires you to first try certain drugs to treat your medical condition before we will cover another drug for that

More information

2018 Formulary Notice of Change Prescription Drug Plans

2018 Formulary Notice of Change Prescription Drug Plans 2018 Formulary Notice of Change Prescription Drug Plans WellCare Prescription Insurance, Inc. Plans in all states: WellCare Classic (PDP) WellCare may add or remove drugs from our formulary during the

More information

Kansas Health Advantage (HMO SNP) 2018 Formulary Quantity Limit Criteria

Kansas Health Advantage (HMO SNP) 2018 Formulary Quantity Limit Criteria APREPITANT Kansas Health Advantage (HMO SNP) 2018 Formulary Aprepitant Oral Capsule 125, 40, 80 Aprepitant Oral Capsule 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL

More information

DIFICID. Products Affected Step 2: DIFICID TABLET 200 MG ORAL. Details

DIFICID. Products Affected Step 2: DIFICID TABLET 200 MG ORAL. Details DIFICID DIFICID TABLET 200 MG ORAL Claim will pay automatically for Dificid if enrollee has a paid claim for at least a 1 days supply of vancomycin in the past. Otherwise, Dificid requires a step therapy

More information

Drugs That Require Step Therapy (ST)

Drugs That Require Step Therapy (ST) Choice Drugs That Require Step Therapy (ST) In some cases, Express Scripts Medicare (PDP) requires you to first try certain drugs to treat your medical condition before we will cover another drug for that

More information

Drugs That Require Step Therapy (ST)

Drugs That Require Step Therapy (ST) Saver Drugs That Require Step Therapy (ST) In some cases, Express Scripts Medicare (PDP) requires you to first try certain drugs to treat your medical condition before we will cover another drug for that

More information

Formulary (Drug List)

Formulary (Drug List) Formulary (Drug List) PacificSource Community Solutions This list was updated on /5/07 Please Read: This document contains information about the drugs we cover on this plan. For a complete, up-to-date

More information

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria GLP1-INSULIN XULTOPHY SOLUTION PEN- INJECTOR 100-3.6 UNIT-MG/ML Claim will pay automatically for Xultophy if enrollee has a paid claim for at least a one day supply for step level 1 agent (LANTUS, LEVEMIR,

More information

CARE N CARE HEALTH PLAN

CARE N CARE HEALTH PLAN PPI DEXILANT CAPSULE DELAYED RELEASE 30 MG ORAL DEXILANT CAPSULE DELAYED RELEASE 60 MG ORAL Claim will pay automatically for Dexilant if enrollee has a paid claim for at least a 1 days supply of lansoprazole,

More information

Medicare Part D 2016 Formulary Changes Service To Senior and OC Preferred

Medicare Part D 2016 Formulary Changes Service To Senior and OC Preferred Medicare Part D 2016 Formulary s Service To Senior and OC Preferred Inter Valley Health Plan may add or remove drugs from our formulary during the year. If we remove a drug from our formulary, add prior

More information

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria

HEALTHTEAM ADVANTAGE 2018 Step Therapy Criteria GLP1-INSULIN XULTOPHY SOLUTION PEN- INJECTOR 100-3.6 UNIT-MG/ML HEALTHTEAM ADVANTAGE Claim will pay automatically for Xultophy if enrollee has a paid claim for at least a one day supply for step level

More information

APREPITANT ARMODAFINIL BELSOMRA BUPAP BUPRENORPHINE HCL BUTALBITAL-ACETAMINOPHEN BUTALBITAL-APAP-CAFF-COD BUTALBITAL-APAP-CAFFEINE

APREPITANT ARMODAFINIL BELSOMRA BUPAP BUPRENORPHINE HCL BUTALBITAL-ACETAMINOPHEN BUTALBITAL-APAP-CAFF-COD BUTALBITAL-APAP-CAFFEINE APREPITANT Aprepitant Oral Capsule 125, 40, 80 Aprepitant Oral Capsule 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL Armodafinil Oral Tablet 150, 200, 250, 50

More information

Peach State Health Plan routinely reviews the medications available on the Preferred Drug

Peach State Health Plan routinely reviews the medications available on the Preferred Drug Effective date: December 27, 2016 Peach State Health Plan Preferred Drug List (PDL) Updates Q4 2016 Peach State Health Plan routinely reviews the medications available on the Preferred Drug List (PDL).

More information

Step Therapy Criteria

Step Therapy Criteria Tier 5 Formulary Step Therapy 2016 Updated: 05/24/2016 Effective: 06/01/2016 What is Step Therapy? Some prescription drugs require step therapy (ST). In some cases, the plan requires you to first try certain

More information

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand

More information

Aetna Better Health Illinois Premier Plan. November 2015 Formulary Updates. October 2015 Formulary Updates

Aetna Better Health Illinois Premier Plan. November 2015 Formulary Updates. October 2015 Formulary Updates Aetna Better Health Illinois Premier Plan November 2015 Formulary Updates desogestrel & ethinyl estradiol tab 0.15 mg-30 mcg RIVASTIGMINE DIS 13.3/24; QL (30 patches/30 days) RIVASTIGMINE DIS 4.6MG/24;

More information

HEALTH SHARE/PROVIDENCE (OHP)

HEALTH SHARE/PROVIDENCE (OHP) HEALTH SHARE/PROVIDENCE (OHP) STEP THERAPY This is a complete list of drugs that have written coverage determination policies. Drugs on this list do not indicate that this particular drug will be covered

More information

These programs and quantity limitations may not apply. Check your certificate or other plan information for benefit details.

These programs and quantity limitations may not apply. Check your certificate or other plan information for benefit details. FlexRx Standard Utilization Management (PA, QL,) Updates January 1, 2018 How to use this drug list This drug list includes updates to Utilization Management (UM) programs. UM may include a prior authorization

More information

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019

ANTICONVULSANTS. Details. Step Therapy Criteria Date Effective: April 1, 2019 Step Therapy Date Effective: April 1, 2019 ANTICONVULSANTS APTIOM TABLET 200 MG ORAL APTIOM TABLET 400 MG ORAL APTIOM TABLET 600 MG ORAL APTIOM TABLET 800 MG ORAL BANZEL SUSPENSION 40 MG/ML ORAL BANZEL

More information

Aetna Better Health of Illinois Medicaid Formulary Updates

Aetna Better Health of Illinois Medicaid Formulary Updates October 2017 o DOXYLAMINE SUCCINATE 25mg-QL o DULOXETINE CAP 40MG DR-QL o GUANFACIN ER TABS (all strengths)-ql o TOBRAMYCIN NEBU SOLUTION- PA August 2017 Aetna Better Health of Illinois Medicaid 2017 Formulary

More information

2018 Medicare Part D Formulary Change

2018 Medicare Part D Formulary Change 2018 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy

More information

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017

Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017 Medicare Part D Drugs that Require Step Therapy Effective 12/01/2017 Providers may call the Pharmacy Help Desk at 800-641-8921 for more information or questions about criteria. The formulary may change

More information

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR

ABILIFY INJ. Products Affected Step 2: ABILIFY MAINTENA PREFILLED SYRINGE 300 MG INTRAMUSCULAR ABILIFY MAINTENA PREFILLED SYRINGE 400 MG INTRAMUSCULAR ABILIFY INJ ABILIFY MAINTENA PREFILLED SYRINGE 300 MG ABILIFY MAINTENA PREFILLED SYRINGE 400 MG ABILIFY MAINTENA SUSPENSION RECONSTITUTED ER 300 MG Claim will pay automatically for ABILIFY MAINTENA if

More information

Pharmacy Updates Summary

Pharmacy Updates Summary All of the following changes were reviewed and approved by the SFHP Pharmacy & Therapeutics (P&T) Committee on 04/15/2015 Effective date: 05/15/2015 Therapeutic Classes reviewed: Testosterone replacement

More information

Tribute 2018 Formulary 2018 Quantity Limit Criteria

Tribute 2018 Formulary 2018 Quantity Limit Criteria APREPITANT Aprepitant ORAL CAPSULE 125, 40, 80 Aprepitant Oral CAPSULE 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL Armodafinil ORAL TABLET 150, 200, 250, 50

More information

WellCare s South Carolina Preferred Drug List Update

WellCare s South Carolina Preferred Drug List Update WellCare s South Carolina Preferred Drug List Update This is a list of changes to our preferred drug list. These are a result of the latest WellCare Pharmacy & Therapeutics meeting held on 09/03/2015.

More information

Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies

Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies Changes to the 2018 BlueCross Secure SM (HMO) & BlueCross Total SM (PPO) Formularies BlueCross BlueShield of South Carolina may add or remove drugs from the formulary during the year. If we remove drugs

More information

2017 Medicare Part D Formulary Change

2017 Medicare Part D Formulary Change 2017 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy

More information

2018 Medicare Part D Formulary Change

2018 Medicare Part D Formulary Change 2018 Medicare Part D Formulary Change We may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, or add prior authorizations, quantity limits and/or step therapy

More information

2017 Formulary Changes Year to Date

2017 Formulary Changes Year to Date 2017 Formulary Changes Year to Date Health Choice Arizona may add or remove drugs from our formulary during the year. If we remove drugs from our formulary, add prior authorization, quantity limits and/or

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Quarterly pharmacy formulary change notice Summary of change: The Pharmacy and Therapeutics Committee (P&T) reviewed and approved the formulary changes listed in the table below on March 29, 2016. What

More information

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria

Mercy Care ALBENDAZOLE. Products Affected. ALBENZA TABLET 200 MG ORAL Details. Criteria. Refer to PA Guideline for approval criteria ALBENDAZOLE Mercy Care ALBENZA TABLET 200 MG ORAL Refer to PA Guideline for approval criteria 1 BRIMONIDINE-TIMOLOL COMBIGAN SOLUTION 0.2-0.5 % OPHTHALMIC Requires use of separate ingredients for at least

More information

Quarterly pharmacy formulary change notice

Quarterly pharmacy formulary change notice Provider Bulletin April 2018 This table is used by HealthKeepers, Inc. to indicate formulary changes applicable to all Anthem HealthKeepers Plus members. These changes were reviewed and approved at the

More information

The following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016.

The following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016. Q4 MHS PDL Changes Provider Notice The following list of recommended PDL changes were reviewed and approved by the MHS P&T Committee on December 14 th, 2016. Table 1: Summary of Medicaid PDL Additions

More information

Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube

Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube Allergan s Blephamide (sulfacetamide/prednisolone ophthalmic ointment) 10%/0.2%, 3.5Gm tube On Aug. 24, 2015, Allergan recalled three lots (86258 expires September 2017, 87189 December 2017 and 87514 February

More information

Neighborhood Medicaid Formulary Changes: June 2017

Neighborhood Medicaid Formulary Changes: June 2017 Neighborhood Medicaid Formulary Changes: June 2017 The following changes to the Neighborhood Medicaid Formulary were recently approved by the Pharmacy and Therapeutics (P&T) Committee. All changes were

More information

Tribute 2018 Formulary 2018 Quantity Limit Criteria

Tribute 2018 Formulary 2018 Quantity Limit Criteria APREPITANT Aprepitant Oral Capsule 125, 40, 80 Aprepitant Oral Capsule 80 & 125 Quantity Limit: 8 EA Per 30 Days Quantity Limit: 12 EA Per 30 Days ARMODAFINIL Armodafinil Oral Tablet 150, 200, 250, 50

More information

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Golden State Medicare Health Plan, Golden (HMO) Last Updated: 09/01/2018

ALBUTEROL - SCORE. Products Affected. Details. Step Therapy Criteria Golden State Medicare Health Plan, Golden (HMO) Last Updated: 09/01/2018 Step Therapy Golden State Medicare Health Plan, Golden (HMO) Last Updated: 09/01/2018 ALBUTEROL - SCORE Ventolin Hfa Trial of ProAir 1 ANTIDEPRESSANTS - SCORE Aplenzin Desvenlafaxine Er TB24 100MG, 50MG

More information

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select Formulary April 1, 2018 Updates. Formulary Alternatives PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Select April 1, 2018 Updates Drug Name adapalene-benzoyl-peroxide Gel 0.1-2.5% (Brand = Epiduo ) prasugrel hcl (Brand = Effient ) vigabatrin pak 500 mg (Brand

More information

Health Partners Medicare Special 2018 Formulary Changes

Health Partners Medicare Special 2018 Formulary Changes Health Partners Medicare Special 2018 Changes Changes occur, for example, because new drugs come on the market, a drug is moved to a different cost-sharing level (tier), or a generic version becomes available.

More information

Pharmacy Formulary Updates for January 2019

Pharmacy Formulary Updates for January 2019 Pharmacy Formulary Updates for January 2019 To offer a pharmacy benefit that is clinically appropriate and cost effective, we constantly review how we cover prescription medications. Periodic adjustments

More information

Step Therapy Requirements. Effective: 11/01/2018

Step Therapy Requirements. Effective: 11/01/2018 Effective: 11/01/2018 Updated 10/2018 ANTIDEPRESSANTS Sharp Health Plan (HMO) TRINTELLIX 10 MG TABLET TRINTELLIX 20 MG TABLET TRINTELLIX 5 MG TABLET VIIBRYD 10 MG (7)-20 MG (23) TABLETS IN A DOSE PACK

More information

UPDATE Ohana QUEST Integration Medicaid

UPDATE Ohana QUEST Integration Medicaid UPDATE Ohana QUEST Integration Medicaid Preferred Drug List June 29, 2015 Dear Provider: At the June 04, 2015 WellCare Pharmacy & Therapeutics Committee meeting, it was decided that the following changes

More information

Emblem Medicaid 3Q18 Formulary Updates

Emblem Medicaid 3Q18 Formulary Updates ALKERAN 2 MG TABLET Removed from Formulary 7/9/2018 AMITIZA 24 MCG CAPSULES Removed from Formulary 7/9/2018 AMITIZA 8 MCG CAPSULE Removed from Formulary 7/9/2018 avo cream topical emulsion Removed from

More information

Aetna Better Health FIDA Plan

Aetna Better Health FIDA Plan Aetna Better Health FIDA Plan May 2016 Formulary Updates ASCOMP/COD - QL; PA FYAVOLV 5MCG; 1MG- PA METOPROLOL TABS 37.5MG, 75MG CIPRODEX LETAIRIS - QL; PA OFEV - QL; PA OTREXUP - ST PRALUENT - QL; PA RASUVO

More information

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details

5-ASA. Products Affected DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED RELEASE. Details 5-ASA DIPENTUM 250 MG CAPSULE LIALDA 1.2 GRAM TABLET,DELAYED You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda or Dipentum. 1 ANTIEMETICS

More information

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release

5-ASA. Products Affected. Details. Dipentum 250 mg capsule. Lialda 1.2 gram tablet,delayed release Updated 11/1/17 5-ASA Dipentum 250 mg capsule Lialda 1.2 gram tablet,delayed release You are required to have previous therapy with balsalazide, Delzicol, Apriso, or Asacol HD before we will cover Lialda

More information

Additional drug coverage

Additional drug coverage Additional drug coverage Bonus Drug List The North Carolina State Health Plan for Teachers and State Employees offers a bonus drug list. The prescription drugs in this list are covered in addition to the

More information

MEDICARE Program Policies & Procedures POLICY NUMBER: Medicare D-111

MEDICARE Program Policies & Procedures POLICY NUMBER: Medicare D-111 POLICY: Medicare Part D Formulary-Level Cumulative Opioid and Opioid/Buprenorphine POS Edits MEDICARE Program Policies & Procedures POLICY NUMBER: Medicare D-111 Policy for contracts H3351, S3521 and H3335

More information

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST)

Plan Year CCHP Senior Program (HMO) Step Therapy Criteria (ST) Plan Year 2016 CCHP Senior Program (HMO) Step Therapy Criteria (ST) Step Therapy: In some cases, CCHP Senior Program (HMO) requires you to first try certain drugs to treat your medical condition before

More information

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES

PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES PRESCRIPTION DRUG PROGRAM FORMULARY UPDATES Generic Additions These generic drugs recently became available in the marketplace. When these generic drugs became available, we began covering them at the

More information

Advance Notification of Amendments to the December 2018 Drug Tariff

Advance Notification of Amendments to the December 2018 Drug Tariff Advance Notification of Amendments to the December 2018 Drug Tariff ADDITIONS Zero Discount Fondaparinux sodium solution for injection pre-filled (ALL) FreeStyle Libre Sensor Oxygen CD cylinder Oxygen

More information